You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股暗盤 | 加科思-B(1167.HK)暗盤段大漲逾30%
格隆匯 12-18 16:29
格隆匯12月18日丨據輝立證券,加科思-B(1167.HK)暗盤段現報19港元,較發行價14港元幅35.7%;在富途證券暗盤段曾漲超40%,現報18.76港元,漲幅34%。公司是一家臨牀階段製藥企業,專注於創新腫瘤療法的自主發現和開發。此次上市全球發售9647.61萬股,其中香港發售4824萬股,國際發售4823.61萬股,每手300股,香港公開發售獲299.59倍認購,淨籌12.631億港元,當中88%擬主要用於相關產品的臨牀開發及商業化。LAV Funds等多家基石投資者已合共認購3322.08萬股發售股份,佔發售完成後公司已發行股本的約4.37%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account